Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: 360iResearch LLP | PRODUCT CODE: 1185714

Cover Image

PUBLISHER: 360iResearch LLP | PRODUCT CODE: 1185714

Liquid Biopsy Market Research Report by Product, Sample, Type, Technology, Indication, End-User, Application, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, High Inflation - Global Forecast 2023-2030

PUBLISHED:
PAGES: 259 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
Online Access - 1 Year (Single User License)
USD 3949
PDF & Excel + Online Access - 1 Year (Single User License)
USD 4949
PDF & Excel + Online Access - 1 Year (Up to 5 User License)
USD 5949
PDF & Excel + Online Access - 1 Year (Site License)
USD 6949
PDF & Excel + Online Access - 1 Year (Enterprise User License)
USD 8949

Add to Cart

Contact us about how to customize the report with add-on data.

The Global Liquid Biopsy Market size was estimated at USD 1,417.69 million in 2022 and expected to reach USD 1,704.64 million in 2023, projecting growth at a CAGR of 20.37% to reach USD 6,250.89 million by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global Liquid Biopsy Market.

Cumulative Impact of Russia-Ukraine Conflict:

We continuously monitor and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people's lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global Liquid Biopsy Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global Liquid Biopsy Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global Liquid Biopsy Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan. This research report categorizes the Global Liquid Biopsy Market in order to forecast the revenues and analyze the trends in each of the following sub-markets.

Based on Product, the market is studied across Cell-free DNA, Circulating Tumor Cells, Circulating Tumor DNA, Exosome, and Extracellular Vesicles.

Based on Sample, the market is studied across Blood Based and Urine Based.

Based on Type, the market is studied across Assay Kits, Instruments, and Services.

Based on Technology, the market is studied across Multi-gene Parallel Analysis using NGS and Single-gene Analysis using PCR Microarrays.

Based on Indication, the market is studied across Cancer Indication and Non-Cancer Indication. The Cancer Indication is further studied across Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer.

Based on End-User, the market is studied across Academic & Research Centers, Clinical Diagnostic Laboratories, Hospitals, and Physician's Office Laboratories.

Based on Application, the market is studied across Early Cancer Screening, Recurrence Monitoring, Therapy Selection, and Treatment Monitoring.

Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Liquid Biopsy Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global Liquid Biopsy Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global Liquid Biopsy Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global Liquid Biopsy Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor's strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Liquid Biopsy Market, including Bio-Rad Laboratories, Inc., Biocept, Inc., Exact Sciences Corporation, Foundation Medicine, Inc., Freenome Holdings, Inc., Guardant Health, Inc., Illumina, Inc., LungLife AI, Inc., Mdxhealth SA, Mesa Labs, Inc., Myriad Genetics, Inc., Natera, Inc., Neogenomics, Inc., PerkinElmer, Inc., Strand Life Sciences Pvt. Ltd., and Thermo Fisher Scientific Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Liquid Biopsy Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Liquid Biopsy Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Liquid Biopsy Market?

4. What is the competitive strategic window for opportunities in the Global Liquid Biopsy Market?

5. What are the technology trends and regulatory frameworks in the Global Liquid Biopsy Market?

6. What is the market share of the leading vendors in the Global Liquid Biopsy Market?

7. What modes and strategic moves are considered suitable for entering the Global Liquid Biopsy Market?

Product Code: MRR-43470FC608C9

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising Incidence and Prevalence of Cancer
      • 5.1.1.2. Increasing Preference for Noninvasive Diagnostic Procedures
      • 5.1.1.3. Availability of Funding to Expand Cancer Research in the Field of Liquid Biopsy
    • 5.1.2. Restraints
      • 5.1.2.1. Low Abundance and Fragile Nature of the Circulating Tumor Cells (CTCs)
    • 5.1.3. Opportunities
      • 5.1.3.1. Significant use of Microarrays and Next-Generation Sequencing (NGS)
      • 5.1.3.2. Ongoing Development of Advanced Liquid Biopsy Assays
    • 5.1.4. Challenges
      • 5.1.4.1. Unclear Regulatory and Reimbursement Scenario
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Cumulative Impact of Russia-Ukraine Conflict
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Threat of Substitutes
    • 5.5.4. Threat of Substitutes
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework
  • 5.8. Client Customization

6. Liquid Biopsy Market, by Product

  • 6.1. Introduction
  • 6.2. Cell-free DNA
  • 6.3. Circulating Tumor Cells
  • 6.4. Circulating Tumor DNA
  • 6.5. Exosome
  • 6.6. Extracellular Vesicles

7. Liquid Biopsy Market, by Sample

  • 7.1. Introduction
  • 7.2. Blood Based
  • 7.3. Urine Based

8. Liquid Biopsy Market, by Type

  • 8.1. Introduction
  • 8.2. Assay Kits
  • 8.3. Instruments
  • 8.4. Services

9. Liquid Biopsy Market, by Technology

  • 9.1. Introduction
  • 9.2. Multi-gene Parallel Analysis using NGS
  • 9.3. Single-gene Analysis using PCR Microarrays

10. Liquid Biopsy Market, by Indication

  • 10.1. Introduction
  • 10.2. Cancer Indication
    • 10.3.1. Breast Cancer
    • 10.3.2. Colorectal Cancer
    • 10.3.3. Lung Cancer
    • 10.3.4. Melanoma
    • 10.3.5. Prostate Cancer
  • 10.3. Non-Cancer Indication

11. Liquid Biopsy Market, by End-User

  • 11.1. Introduction
  • 11.2. Academic & Research Centers
  • 11.3. Clinical Diagnostic Laboratories
  • 11.4. Hospitals
  • 11.5. Physician's Office Laboratories

12. Liquid Biopsy Market, by Application

  • 12.1. Introduction
  • 12.2. Early Cancer Screening
  • 12.3. Recurrence Monitoring
  • 12.4. Therapy Selection
  • 12.5. Treatment Monitoring

13. Americas Liquid Biopsy Market

  • 13.1. Introduction
  • 13.2. Argentina
  • 13.3. Brazil
  • 13.4. Canada
  • 13.5. Mexico
  • 13.6. United States

14. Asia-Pacific Liquid Biopsy Market

  • 14.1. Introduction
  • 14.2. Australia
  • 14.3. China
  • 14.4. India
  • 14.5. Indonesia
  • 14.6. Japan
  • 14.7. Malaysia
  • 14.8. Philippines
  • 14.9. Singapore
  • 14.10. South Korea
  • 14.11. Taiwan
  • 14.12. Thailand
  • 14.13. Vietnam

15. Europe, Middle East & Africa Liquid Biopsy Market

  • 15.1. Introduction
  • 15.2. Denmark
  • 15.3. Egypt
  • 15.4. Finland
  • 15.5. France
  • 15.6. Germany
  • 15.7. Israel
  • 15.8. Italy
  • 15.9. Netherlands
  • 15.10. Nigeria
  • 15.11. Norway
  • 15.12. Poland
  • 15.13. Qatar
  • 15.14. Russia
  • 15.15. Saudi Arabia
  • 15.16. South Africa
  • 15.17. Spain
  • 15.18. Sweden
  • 15.19. Switzerland
  • 15.20. Turkey
  • 15.21. United Arab Emirates
  • 15.22. United Kingdom

16. Competitive Landscape

  • 16.1. FPNV Positioning Matrix
    • 16.1.1. Quadrants
    • 16.1.2. Business Strategy
    • 16.1.3. Product Satisfaction
  • 16.2. Market Ranking Analysis, By Key Player
  • 16.3. Market Share Analysis, By Key Player
  • 16.4. Product Portfolio Analysis, By Key Player
  • 16.5. Competitive Scenario
    • 16.5.1. Merger & Acquisition
    • 16.5.2. Agreement, Collaboration, & Partnership
    • 16.5.3. New Product Launch & Enhancement
    • 16.5.4. Investment & Funding
    • 16.5.5. Award, Recognition, & Expansion

17. Company Usability Profiles

  • 17.1. Bio-Rad Laboratories, Inc.
  • 17.2. Biocept, Inc.
  • 17.3. Exact Sciences Corporation
  • 17.4. Foundation Medicine, Inc.
  • 17.5. Freenome Holdings, Inc.
  • 17.6. Guardant Health, Inc.
  • 17.7. Illumina, Inc.
  • 17.8. LungLife AI, Inc.
  • 17.9. Mdxhealth SA
  • 17.10. Mesa Labs, Inc.
  • 17.11. Myriad Genetics, Inc.
  • 17.12. Natera, Inc.
  • 17.13. Neogenomics, Inc.
  • 17.14. PerkinElmer, Inc.
  • 17.15. Strand Life Sciences Pvt. Ltd.
  • 17.16. Thermo Fisher Scientific Inc.

18. Appendix

  • 18.1. Discussion Guide
  • 18.2. License & Pricing
Product Code: MRR-43470FC608C9

LIST OF FIGURES

  • FIGURE 1. GLOBAL LIQUID BIOPSY MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL LIQUID BIOPSY MARKET SIZE, 2022 VS 2030
  • FIGURE 3. GLOBAL LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL LIQUID BIOPSY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. GLOBAL LIQUID BIOPSY MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL LIQUID BIOPSY MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2030
  • FIGURE 7. GLOBAL LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 8. GLOBAL LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL LIQUID BIOPSY MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
  • FIGURE 10. GLOBAL LIQUID BIOPSY MARKET DYNAMICS
  • FIGURE 11. GLOBAL LIQUID BIOPSY MARKET PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 12. GLOBAL LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 13. GLOBAL LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL LIQUID BIOPSY MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT, 2030
  • FIGURE 15. GLOBAL LIQUID BIOPSY MARKET SIZE, BY CELL-FREE DNA, 2018-2030 (USD MILLION)
  • FIGURE 16. GLOBAL LIQUID BIOPSY MARKET SIZE, BY CIRCULATING TUMOR CELLS, 2018-2030 (USD MILLION)
  • FIGURE 17. GLOBAL LIQUID BIOPSY MARKET SIZE, BY CIRCULATING TUMOR DNA, 2018-2030 (USD MILLION)
  • FIGURE 18. GLOBAL LIQUID BIOPSY MARKET SIZE, BY EXOSOME, 2018-2030 (USD MILLION)
  • FIGURE 19. GLOBAL LIQUID BIOPSY MARKET SIZE, BY EXTRACELLULAR VESICLES, 2018-2030 (USD MILLION)
  • FIGURE 20. GLOBAL LIQUID BIOPSY MARKET SIZE, BY SAMPLE, 2022 VS 2030 (%)
  • FIGURE 21. GLOBAL LIQUID BIOPSY MARKET SIZE, BY SAMPLE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 22. GLOBAL LIQUID BIOPSY MARKET COMPETITIVE STRATEGIC WINDOW, BY SAMPLE, 2030
  • FIGURE 23. GLOBAL LIQUID BIOPSY MARKET SIZE, BY BLOOD BASED, 2018-2030 (USD MILLION)
  • FIGURE 24. GLOBAL LIQUID BIOPSY MARKET SIZE, BY URINE BASED, 2018-2030 (USD MILLION)
  • FIGURE 25. GLOBAL LIQUID BIOPSY MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 26. GLOBAL LIQUID BIOPSY MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 27. GLOBAL LIQUID BIOPSY MARKET COMPETITIVE STRATEGIC WINDOW, BY TYPE, 2030
  • FIGURE 28. GLOBAL LIQUID BIOPSY MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
  • FIGURE 29. GLOBAL LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • FIGURE 30. GLOBAL LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • FIGURE 31. GLOBAL LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
  • FIGURE 32. GLOBAL LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 33. GLOBAL LIQUID BIOPSY MARKET COMPETITIVE STRATEGIC WINDOW, BY TECHNOLOGY, 2030
  • FIGURE 34. GLOBAL LIQUID BIOPSY MARKET SIZE, BY MULTI-GENE PARALLEL ANALYSIS USING NGS, 2018-2030 (USD MILLION)
  • FIGURE 35. GLOBAL LIQUID BIOPSY MARKET SIZE, BY SINGLE-GENE ANALYSIS USING PCR MICROARRAYS, 2018-2030 (USD MILLION)
  • FIGURE 36. GLOBAL LIQUID BIOPSY MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
  • FIGURE 37. GLOBAL LIQUID BIOPSY MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 38. GLOBAL LIQUID BIOPSY MARKET COMPETITIVE STRATEGIC WINDOW, BY INDICATION, 2030
  • FIGURE 39. GLOBAL LIQUID BIOPSY MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • FIGURE 40. GLOBAL LIQUID BIOPSY MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
  • FIGURE 41. GLOBAL LIQUID BIOPSY MARKET SIZE, BY COLORECTAL CANCER, 2018-2030 (USD MILLION)
  • FIGURE 42. GLOBAL LIQUID BIOPSY MARKET SIZE, BY LUNG CANCER, 2018-2030 (USD MILLION)
  • FIGURE 43. GLOBAL LIQUID BIOPSY MARKET SIZE, BY MELANOMA, 2018-2030 (USD MILLION)
  • FIGURE 44. GLOBAL LIQUID BIOPSY MARKET SIZE, BY PROSTATE CANCER, 2018-2030 (USD MILLION)
  • FIGURE 45. GLOBAL LIQUID BIOPSY MARKET SIZE, BY NON-CANCER INDICATION, 2018-2030 (USD MILLION)
  • FIGURE 46. GLOBAL LIQUID BIOPSY MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 47. GLOBAL LIQUID BIOPSY MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 48. GLOBAL LIQUID BIOPSY MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USER, 2030
  • FIGURE 49. GLOBAL LIQUID BIOPSY MARKET SIZE, BY ACADEMIC & RESEARCH CENTERS, 2018-2030 (USD MILLION)
  • FIGURE 50. GLOBAL LIQUID BIOPSY MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • FIGURE 51. GLOBAL LIQUID BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • FIGURE 52. GLOBAL LIQUID BIOPSY MARKET SIZE, BY PHYSICIAN'S OFFICE LABORATORIES, 2018-2030 (USD MILLION)
  • FIGURE 53. GLOBAL LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 54. GLOBAL LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 55. GLOBAL LIQUID BIOPSY MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2030
  • FIGURE 56. GLOBAL LIQUID BIOPSY MARKET SIZE, BY EARLY CANCER SCREENING, 2018-2030 (USD MILLION)
  • FIGURE 57. GLOBAL LIQUID BIOPSY MARKET SIZE, BY RECURRENCE MONITORING, 2018-2030 (USD MILLION)
  • FIGURE 58. GLOBAL LIQUID BIOPSY MARKET SIZE, BY THERAPY SELECTION, 2018-2030 (USD MILLION)
  • FIGURE 59. GLOBAL LIQUID BIOPSY MARKET SIZE, BY TREATMENT MONITORING, 2018-2030 (USD MILLION)
  • FIGURE 60. AMERICAS LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 61. AMERICAS LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 62. AMERICAS LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 63. AMERICAS LIQUID BIOPSY MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
  • FIGURE 64. ARGENTINA LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 65. BRAZIL LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 66. CANADA LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 67. MEXICO LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 68. UNITED STATES LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 69. UNITED STATES LIQUID BIOPSY MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 70. UNITED STATES LIQUID BIOPSY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 71. UNITED STATES LIQUID BIOPSY MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
  • FIGURE 72. ASIA-PACIFIC LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 73. ASIA-PACIFIC LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 74. ASIA-PACIFIC LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 75. ASIA-PACIFIC LIQUID BIOPSY MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
  • FIGURE 76. AUSTRALIA LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 77. CHINA LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 78. INDIA LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 79. INDONESIA LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 80. JAPAN LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 81. MALAYSIA LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 82. PHILIPPINES LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 83. SINGAPORE LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 84. SOUTH KOREA LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 85. TAIWAN LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 86. THAILAND LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 87. VIETNAM LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 88. EUROPE, MIDDLE EAST & AFRICA LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 89. EUROPE, MIDDLE EAST & AFRICA LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 90. EUROPE, MIDDLE EAST & AFRICA LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 91. EUROPE, MIDDLE EAST & AFRICA LIQUID BIOPSY MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
  • FIGURE 92. DENMARK LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 93. EGYPT LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 94. FINLAND LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 95. FRANCE LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 96. GERMANY LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 97. ISRAEL LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 98. ITALY LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 99. NETHERLANDS LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 100. NIGERIA LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 101. NORWAY LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 102. POLAND LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 103. QATAR LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 104. RUSSIA LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 105. SAUDI ARABIA LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 106. SOUTH AFRICA LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 107. SPAIN LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 108. SWEDEN LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 109. SWITZERLAND LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 110. TURKEY LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 111. UNITED ARAB EMIRATES LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 112. UNITED KINGDOM LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 113. GLOBAL LIQUID BIOPSY MARKET: FPNV POSITIONING MATRIX, 2022
  • FIGURE 114. GLOBAL LIQUID BIOPSY MARKET SHARE, BY KEY PLAYER, 2022
  • FIGURE 115. GLOBAL LIQUID BIOPSY MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022

LIST OF TABLES

  • TABLE 1. GLOBAL LIQUID BIOPSY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. GLOBAL LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL LIQUID BIOPSY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GLOBAL LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 7. GLOBAL LIQUID BIOPSY MARKET SIZE, BY CELL-FREE DNA, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL LIQUID BIOPSY MARKET SIZE, BY CELL-FREE DNA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL LIQUID BIOPSY MARKET SIZE, BY CELL-FREE DNA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL LIQUID BIOPSY MARKET SIZE, BY CIRCULATING TUMOR CELLS, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL LIQUID BIOPSY MARKET SIZE, BY CIRCULATING TUMOR CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL LIQUID BIOPSY MARKET SIZE, BY CIRCULATING TUMOR CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL LIQUID BIOPSY MARKET SIZE, BY CIRCULATING TUMOR DNA, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL LIQUID BIOPSY MARKET SIZE, BY CIRCULATING TUMOR DNA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL LIQUID BIOPSY MARKET SIZE, BY CIRCULATING TUMOR DNA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL LIQUID BIOPSY MARKET SIZE, BY EXOSOME, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL LIQUID BIOPSY MARKET SIZE, BY EXOSOME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL LIQUID BIOPSY MARKET SIZE, BY EXOSOME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL LIQUID BIOPSY MARKET SIZE, BY EXTRACELLULAR VESICLES, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL LIQUID BIOPSY MARKET SIZE, BY EXTRACELLULAR VESICLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL LIQUID BIOPSY MARKET SIZE, BY EXTRACELLULAR VESICLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL LIQUID BIOPSY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL LIQUID BIOPSY MARKET SIZE, BY BLOOD BASED, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL LIQUID BIOPSY MARKET SIZE, BY BLOOD BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL LIQUID BIOPSY MARKET SIZE, BY BLOOD BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL LIQUID BIOPSY MARKET SIZE, BY URINE BASED, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL LIQUID BIOPSY MARKET SIZE, BY URINE BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL LIQUID BIOPSY MARKET SIZE, BY URINE BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL LIQUID BIOPSY MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL LIQUID BIOPSY MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL LIQUID BIOPSY MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL LIQUID BIOPSY MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL LIQUID BIOPSY MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL LIQUID BIOPSY MARKET SIZE, BY MULTI-GENE PARALLEL ANALYSIS USING NGS, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL LIQUID BIOPSY MARKET SIZE, BY MULTI-GENE PARALLEL ANALYSIS USING NGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL LIQUID BIOPSY MARKET SIZE, BY MULTI-GENE PARALLEL ANALYSIS USING NGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL LIQUID BIOPSY MARKET SIZE, BY SINGLE-GENE ANALYSIS USING PCR MICROARRAYS, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL LIQUID BIOPSY MARKET SIZE, BY SINGLE-GENE ANALYSIS USING PCR MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL LIQUID BIOPSY MARKET SIZE, BY SINGLE-GENE ANALYSIS USING PCR MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL LIQUID BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL LIQUID BIOPSY MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL LIQUID BIOPSY MARKET SIZE, BY CANCER INDICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL LIQUID BIOPSY MARKET SIZE, BY CANCER INDICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL LIQUID BIOPSY MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL LIQUID BIOPSY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL LIQUID BIOPSY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL LIQUID BIOPSY MARKET SIZE, BY COLORECTAL CANCER, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL LIQUID BIOPSY MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL LIQUID BIOPSY MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL LIQUID BIOPSY MARKET SIZE, BY LUNG CANCER, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL LIQUID BIOPSY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 58. GLOBAL LIQUID BIOPSY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 59. GLOBAL LIQUID BIOPSY MARKET SIZE, BY MELANOMA, 2018-2030 (USD MILLION)
  • TABLE 60. GLOBAL LIQUID BIOPSY MARKET SIZE, BY MELANOMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 61. GLOBAL LIQUID BIOPSY MARKET SIZE, BY MELANOMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 62. GLOBAL LIQUID BIOPSY MARKET SIZE, BY PROSTATE CANCER, 2018-2030 (USD MILLION)
  • TABLE 63. GLOBAL LIQUID BIOPSY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 64. GLOBAL LIQUID BIOPSY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 65. GLOBAL LIQUID BIOPSY MARKET SIZE, BY NON-CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 66. GLOBAL LIQUID BIOPSY MARKET SIZE, BY NON-CANCER INDICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 67. GLOBAL LIQUID BIOPSY MARKET SIZE, BY NON-CANCER INDICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 68. GLOBAL LIQUID BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. GLOBAL LIQUID BIOPSY MARKET SIZE, BY ACADEMIC & RESEARCH CENTERS, 2018-2030 (USD MILLION)
  • TABLE 70. GLOBAL LIQUID BIOPSY MARKET SIZE, BY ACADEMIC & RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 71. GLOBAL LIQUID BIOPSY MARKET SIZE, BY ACADEMIC & RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 72. GLOBAL LIQUID BIOPSY MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 73. GLOBAL LIQUID BIOPSY MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 74. GLOBAL LIQUID BIOPSY MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 75. GLOBAL LIQUID BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 76. GLOBAL LIQUID BIOPSY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 77. GLOBAL LIQUID BIOPSY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 78. GLOBAL LIQUID BIOPSY MARKET SIZE, BY PHYSICIAN'S OFFICE LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 79. GLOBAL LIQUID BIOPSY MARKET SIZE, BY PHYSICIAN'S OFFICE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 80. GLOBAL LIQUID BIOPSY MARKET SIZE, BY PHYSICIAN'S OFFICE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 81. GLOBAL LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. GLOBAL LIQUID BIOPSY MARKET SIZE, BY EARLY CANCER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 83. GLOBAL LIQUID BIOPSY MARKET SIZE, BY EARLY CANCER SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 84. GLOBAL LIQUID BIOPSY MARKET SIZE, BY EARLY CANCER SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 85. GLOBAL LIQUID BIOPSY MARKET SIZE, BY RECURRENCE MONITORING, 2018-2030 (USD MILLION)
  • TABLE 86. GLOBAL LIQUID BIOPSY MARKET SIZE, BY RECURRENCE MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 87. GLOBAL LIQUID BIOPSY MARKET SIZE, BY RECURRENCE MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 88. GLOBAL LIQUID BIOPSY MARKET SIZE, BY THERAPY SELECTION, 2018-2030 (USD MILLION)
  • TABLE 89. GLOBAL LIQUID BIOPSY MARKET SIZE, BY THERAPY SELECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 90. GLOBAL LIQUID BIOPSY MARKET SIZE, BY THERAPY SELECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 91. GLOBAL LIQUID BIOPSY MARKET SIZE, BY TREATMENT MONITORING, 2018-2030 (USD MILLION)
  • TABLE 92. GLOBAL LIQUID BIOPSY MARKET SIZE, BY TREATMENT MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 93. GLOBAL LIQUID BIOPSY MARKET SIZE, BY TREATMENT MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 94. AMERICAS LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 95. AMERICAS LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 96. AMERICAS LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. AMERICAS LIQUID BIOPSY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 98. AMERICAS LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. AMERICAS LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. AMERICAS LIQUID BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. AMERICAS LIQUID BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. AMERICAS LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ARGENTINA LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 104. ARGENTINA LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. ARGENTINA LIQUID BIOPSY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 106. ARGENTINA LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. ARGENTINA LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. ARGENTINA LIQUID BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 109. ARGENTINA LIQUID BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. ARGENTINA LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. BRAZIL LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 112. BRAZIL LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. BRAZIL LIQUID BIOPSY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 114. BRAZIL LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. BRAZIL LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. BRAZIL LIQUID BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 117. BRAZIL LIQUID BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. BRAZIL LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. CANADA LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 120. CANADA LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. CANADA LIQUID BIOPSY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 122. CANADA LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. CANADA LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. CANADA LIQUID BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. CANADA LIQUID BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. CANADA LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. MEXICO LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 128. MEXICO LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. MEXICO LIQUID BIOPSY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 130. MEXICO LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. MEXICO LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 132. MEXICO LIQUID BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 133. MEXICO LIQUID BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. MEXICO LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. UNITED STATES LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 136. UNITED STATES LIQUID BIOPSY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED STATES LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED STATES LIQUID BIOPSY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED STATES LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED STATES LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED STATES LIQUID BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED STATES LIQUID BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED STATES LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC LIQUID BIOPSY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC LIQUID BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC LIQUID BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 154. AUSTRALIA LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA LIQUID BIOPSY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 156. AUSTRALIA LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. AUSTRALIA LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 158. AUSTRALIA LIQUID BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 159. AUSTRALIA LIQUID BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. AUSTRALIA LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. CHINA LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 162. CHINA LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. CHINA LIQUID BIOPSY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 164. CHINA LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. CHINA LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 166. CHINA LIQUID BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 167. CHINA LIQUID BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. CHINA LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. INDIA LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 170. INDIA LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. INDIA LIQUID BIOPSY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 172. INDIA LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. INDIA LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 174. INDIA LIQUID BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 175. INDIA LIQUID BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. INDIA LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. INDONESIA LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 178. INDONESIA LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. INDONESIA LIQUID BIOPSY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 180. INDONESIA LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. INDONESIA LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 182. INDONESIA LIQUID BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 183. INDONESIA LIQUID BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. INDONESIA LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. JAPAN LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 186. JAPAN LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. JAPAN LIQUID BIOPSY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 188. JAPAN LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. JAPAN LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 190. JAPAN LIQUID BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 191. JAPAN LIQUID BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. JAPAN LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. MALAYSIA LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 194. MALAYSIA LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 195. MALAYSIA LIQUID BIOPSY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 196. MALAYSIA LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. MALAYSIA LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 198. MALAYSIA LIQUID BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 199. MALAYSIA LIQUID BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. MALAYSIA LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 201. PHILIPPINES LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 202. PHILIPPINES LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. PHILIPPINES LIQUID BIOPSY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 204. PHILIPPINES LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. PHILIPPINES LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 206. PHILIPPINES LIQUID BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 207. PHILIPPINES LIQUID BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 208. PHILIPPINES LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. SINGAPORE LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 210. SINGAPORE LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 211. SINGAPORE LIQUID BIOPSY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 212. SINGAPORE LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. SINGAPORE LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 214. SINGAPORE LIQUID BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SINGAPORE LIQUID BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. SINGAPORE LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. SOUTH KOREA LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 218. SOUTH KOREA LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. SOUTH KOREA LIQUID BIOPSY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 220. SOUTH KOREA LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. SOUTH KOREA LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 222. SOUTH KOREA LIQUID BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 223. SOUTH KOREA LIQUID BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. SOUTH KOREA LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. TAIWAN LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 226. TAIWAN LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. TAIWAN LIQUID BIOPSY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 228. TAIWAN LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. TAIWAN LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 230. TAIWAN LIQUID BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 231. TAIWAN LIQUID BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 232. TAIWAN LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. THAILAND LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 234. THAILAND LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 235. THAILAND LIQUID BIOPSY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 236. THAILAND LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. THAILAND LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 238. THAILAND LIQUID BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 239. THAILAND LIQUID BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 240. THAILAND LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 241. VIETNAM LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 242. VIETNAM LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 243. VIETNAM LIQUID BIOPSY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 244. VIETNAM LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. VIETNAM LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 246. VIETNAM LIQUID BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 247. VIETNAM LIQUID BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 248. VIETNAM LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA LIQUID BIOPSY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA LIQUID BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA LIQUID BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 258. DENMARK LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 259. DENMARK LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 260. DENMARK LIQUID BIOPSY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 261. DENMARK LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. DENMARK LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 263. DENMARK LIQUID BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 264. DENMARK LIQUID BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 265. DENMARK LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 266. EGYPT LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 267. EGYPT LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 268. EGYPT LIQUID BIOPSY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 269. EGYPT LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. EGYPT LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 271. EGYPT LIQUID BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 272. EGYPT LIQUID BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 273. EGYPT LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 274. FINLAND LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 275. FINLAND LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 276. FINLAND LIQUID BIOPSY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 277. FINLAND LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 278. FINLAND LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 279. FINLAND LIQUID BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 280. FINLAND LIQUID BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 281. FINLAND LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 282. FRANCE LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 283. FRANCE LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 284. FRANCE LIQUID BIOPSY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 285. FRANCE LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 286. FRANCE LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 287. FRANCE LIQUID BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 288. FRANCE LIQUID BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 289. FRANCE LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 290. GERMANY LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 291. GERMANY LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 292. GERMANY LIQUID BIOPSY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 293. GERMANY LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 294. GERMANY LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 295. GERMANY LIQUID BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 296. GERMANY LIQUID BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 297. GERMANY LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 298. ISRAEL LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 299. ISRAEL LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 300. ISRAEL LIQUID BIOPSY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 301. ISRAEL LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 302. ISRAEL LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 303. ISRAEL LIQUID BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 304. ISRAEL LIQUID BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 305. ISRAEL LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 306. ITALY LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 307. ITALY LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 308. ITALY LIQUID BIOPSY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 309. ITALY LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 310. ITALY LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 311. ITALY LIQUID BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 312. ITALY LIQUID BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 313. ITALY LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 314. NETHERLANDS LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 315. NETHERLANDS LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 316. NETHERLANDS LIQUID BIOPSY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 317. NETHERLANDS LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 318. NETHERLANDS LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 319. NETHERLANDS LIQUID BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 320. NETHERLANDS LIQUID BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 321. NETHERLANDS LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 322. NIGERIA LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 323. NIGERIA LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 324. NIGERIA LIQUID BIOPSY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 325. NIGERIA LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 326. NIGERIA LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 327. NIGERIA LIQUID BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 328. NIGERIA LIQUID BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 329. NIGERIA LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 330. NORWAY LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 331. NORWAY LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 332. NORWAY LIQUID BIOPSY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 333. NORWAY LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 334. NORWAY LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 335. NORWAY LIQUID BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 336. NORWAY LIQUID BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 337. NORWAY LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 338. POLAND LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 339. POLAND LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 340. POLAND LIQUID BIOPSY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 341. POLAND LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 342. POLAND LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 343. POLAND LIQUID BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 344. POLAND LIQUID BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 345. POLAND LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 346. QATAR LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 347. QATAR LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 348. QATAR LIQUID BIOPSY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 349. QATAR LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 350. QATAR LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 351. QATAR LIQUID BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 352. QATAR LIQUID BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 353. QATAR LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 354. RUSSIA LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 355. RUSSIA LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 356. RUSSIA LIQUID BIOPSY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 357. RUSSIA LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 358. RUSSIA LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 359. RUSSIA LIQUID BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 360. RUSSIA LIQUID BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 361. RUSSIA LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 362. SAUDI ARABIA LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 363. SAUDI ARABIA LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 364. SAUDI ARABIA LIQUID BIOPSY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 365. SAUDI ARABIA LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 366. SAUDI ARABIA LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 367. SAUDI ARABIA LIQUID BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 368. SAUDI ARABIA LIQUID BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 369. SAUDI ARABIA LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 370. SOUTH AFRICA LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 371. SOUTH AFRICA LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 372. SOUTH AFRICA LIQUID BIOPSY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 373. SOUTH AFRICA LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 374. SOUTH AFRICA LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 375. SOUTH AFRICA LIQUID BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 376. SOUTH AFRICA LIQUID BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 377. SOUTH AFRICA LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 378. SPAIN LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 379. SPAIN LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 380. SPAIN LIQUID BIOPSY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 381. SPAIN LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 382. SPAIN LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-203
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!